Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
NeueHealth, Inc.Listing unverified | ExerciseD (derivative) | — | SEC | |
NeueHealth, Inc.Listing unverified | Other | $3.7K | SEC | |
NeueHealth, Inc.Listing unverified | Sell | $1.9K | SEC | |
NeueHealth, Inc.Listing unverified | Exercise | $3.7K | SEC | |
NeueHealth, Inc.Listing unverified | Other | — | SEC | |
NeueHealth, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
NeueHealth, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
NeueHealth, Inc.Listing unverified | Other | $1.9K | SEC | |
Mirum Pharmaceuticals, Inc.Listing on record | Other | — | SEC | |
GENOCEA BIOSCIENCES, INC.Listing unverified | Sell | $415.2K | SEC | |
GENOCEA BIOSCIENCES, INC.Listing unverified | Sell | $355.6K | SEC | |
Metacrine, Inc.Listing unverified | Sell | $49.6K | SEC | |
Metacrine, Inc.Listing unverified | Sell | $155.5K | SEC | |
Metacrine, Inc.Listing unverified | Sell | $288.8K | SEC | |
Regulus Therapeutics Inc.Listing unverified | Buy | $2.7M | SEC | |
Regulus Therapeutics Inc.Listing unverified | BuyD (derivative) | $1.6M | SEC | |
Regulus Therapeutics Inc.Listing unverified | BuyD (derivative) | $681.1K | SEC | |
Akouos, Inc.Listing unverified | Other | — | SEC | |
Akouos, Inc.Listing unverified | Other | — | SEC | |
Akouos, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Akouos, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Akouos, Inc.Listing unverified | Other | — | SEC | |
Akouos, Inc.Listing unverified | Buy | $10M | SEC | |
Akouos, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Trevi Therapeutics, Inc.Listing on record | Other | — | SEC |